Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04667871
Other study ID # XZZ-meibomian gland
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date August 1, 2017
Est. completion date September 1, 2020

Study information

Verified date November 2020
Source Wenzhou Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

50 participants at Eye Hospital of Wenzhou Medical University during August, 2017 to July, 2020 will be enrolled in this study. To study the effect of cataract supermammary surgery on the morphology and function of meibomian glands


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date September 1, 2020
Est. primary completion date July 1, 2020
Accepts healthy volunteers No
Gender All
Age group 38 Years to 87 Years
Eligibility Inclusion Criteria: - Previously untreated patients with xerophthalmia - Undergoing cataract hyperemulsification surgery Exclusion Criteria: - No history of ocular surgery and trauma - Any eye diseases except xerophthalmia - No treated for xerophthalmia before - Successful completion of follow-ups

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
cataract surgery
Eyes for cataract surgery

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Yune Zhao

Outcome

Type Measure Description Time frame Safety issue
Primary OSDI scale survey OSDI scale survey 08/2017 to 07/2020
Primary tear meniscus height(mm) tear meniscus height(mm) 08/2017 to 07/2020
Primary first tear film rupture time(s) first tear film rupture time(s) 08/2017 to 07/2020
Primary average tear film rupture time(s) average tear film rupture time(s) 08/2017 to 07/2020
Primary the range of meibomian gland missing(%) the range of meibomian gland missing(%) 08/2017 to 07/2020
Primary meibomian gland average diameter (mm) meibomian gland average diameter (mm) 08/2017 to 07/2020
Primary meibomian gland length (mm) meibomian gland length (mm) 08/2017 to 07/2020
Primary meibomian gland area (mm^2) meibomian gland area (mm^2) 08/2017 to 07/2020
Primary meibomian gland deformation coefficient meibomian gland deformation coefficient 08/2017 to 07/2020
Primary meibomian gland total proportion of glands (%) meibomian gland total proportion of glands (%) 08/2017 to 07/2020
Primary meibomian gland imaging value meibomian gland imaging value 08/2017 to 07/2020
See also
  Status Clinical Trial Phase
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT04884243 - Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction Phase 2
Active, not recruiting NCT04425551 - Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction N/A
Terminated NCT02596919 - Fast Infrared Meibography (Photography) N/A
Completed NCT01207752 - The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction N/A
Completed NCT05162261 - to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction N/A
Recruiting NCT06064071 - Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD N/A
Completed NCT03652051 - A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED) Phase 2
Recruiting NCT03767530 - Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction N/A
Active, not recruiting NCT05577910 - Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD N/A
Completed NCT04889950 - Clinical Study to Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction N/A
Recruiting NCT06004895 - Mechanisms of Light-based Therapies for Dry Eye Disease N/A
Completed NCT04147962 - Intense Pulsed Light in Meibomian Gland Dysfunctions
Completed NCT02256969 - Intraductal Meibomian Gland Probing Trial Phase 4
Recruiting NCT05089591 - Intense Pulsed Light in Meibomian Gland Dysfunction N/A
Completed NCT04500821 - Evaluation of the LipiFlow System With a New Activator N/A
Completed NCT03318874 - Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction Phase 4
Completed NCT06278584 - iLux Treatment for Meibomian Gland Dysfunction N/A
Recruiting NCT04052841 - Morphological Analysis of Meibomian Glands N/A
Completed NCT05028491 - The Influence of Meibomian Gland Expression on Corneal Aberrations in MGD Patients